The Female Health Company Reports: 

 

The Female Health Company Reports Purchase of Shares by Director

 

 

The Female Health Company reported that Stephen M. Dearholt, a director, has purchased 276,667 shares of its common stock during the last 30 days. Mr. Dearholt’s aggregate beneficial ownership now totals 1,769,451 shares of the Company’s common stock.

 

The Female Health Company, based in Chicago, owns certain worldwide rights to the Female Condom including patents which have been issued in the United States, United Kingdom, Japan, France, Italy, Germany, Spain, The People’s Republic of China, Canada, New Zealand, South Korea and Australia. The Female Condom is the only available product controlled by a woman that protects against sexually transmitted diseases including HIV/AIDS, and unintended pregnancy.

 

"Safe Harbor" Statement under the Private Securities Litigation Reform Action of 1995: The statement in this release which are not historical fact are forward-looking statements based upon the Company’s current plans and strategies, and reflect the Company’s current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of governmental regulations, both in the United States and abroad; the effects of competitive products and pricing pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company’s press releases, shareholder communication and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company’s operations may vary from those currently anticipated.

 

 

For more information about The Female Health Company toll-free via fax,

dial 1-800-PRO-INFO and enter company code "FHCO."

Also, visit the Company's web site, www.femalehealth.com.

 

# # #

 

 

If you have any questions or comments, please send them to us info@femalehealth.com